Abstract
A study comparing sequential biopsies suggests that repeating whole-genome sequencing is not necessary in most cases. Researchers found that 99% of actionable mutations detected by the initial round of sequencing were present in later biopsies, although repeating the test could be beneficial for patients receiving certain therapies.
©2021 American Association for Cancer Research.
2021
American Association for Cancer Research.
You do not currently have access to this content.